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Abstract

This book of readings is intended for courses in Global Health. The editors asked Prof. Stillwaggon to
contribute a chapter summarizing her years of work on the spread of HIV/AIDS in populations among whom
bacterial, fungal, parasitic, and viral diseases are extremely common, particularly in sub-Saharan Africa. Her
work has demonstrated that differences in behavior cannot explain differences in HIV rates between world
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field of global health itself, the readings focus on the public health challenges faced by low- and middleincome countries as well as the persistent problems of health disparities in high-income countries.

This book chapter is available at The Cupola: Scholarship at Gettysburg College: https://cupola.gettysburg.edu/econfac/31

FOUNDATIONS OF
GLOBAL HEALTH
An Interdisciplinary Reader

ED ITED BY

PETER J. BROWN
EMORY UNIVERSITY

SVEA CLOSSER
MIDDLEBURY COLLEGE

NEW YORK

OXFORD

OXFORD UNIVERSITY PRESS

Oxford University Press is a department of the University of Oxford. It furthers
the University's objective of excellence in research, scholarship, and education by
publishing worldwide. Oxford is a registered trade mark of Oxford University Press
in the UK and certain other countries.

Published in the United States of America by Oxford University Press
198 Madison Avenue, New York, NY 10016, United States of America.

® 2019 by Oxford University Press
For titles covered by Section 112 of the US Higher Education Opportunity Act,
please visit www.oup.com/us/he for the latest information about pricing and
alternate formats.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval
system, or transmitted, in any form or by any means, without the prior permission
in writing of Oxford University Press, or as expressly permitted by law, by license, or
under terms agreed with the appropriate reproduction rights organization. Inquiries
concerning reproduction outside the scope of the above should be sent to the Rights
Department, Oxford University Press, at the address above.
You must not circulate this work in any other form
and you must impose this same condition on any acquirer.

Library of Congress Cataloging-in-Publication Data
Names: Brown, Peter J., editor.
Title: Foundations of global health : an interdisciplinary reader I edited by
Peter J. Brown, Emory University, Svea Closser, Middlebury College.
Description: New York : Oxford University Press, [2019] | Includes
bibliographical references.
Identifiers: LCCN 2017043138 | ISBN 9780190647940 (paperback : alk. paper)
Subjects: LCSH: World health—Textbooks. | Public health—Textbooks.
Classification: LCC RA441 .F675 2019 | DDC 362.1—dc23
LC record available at https://lccn.loc.gov/2017043138
987654321

Printed by Sheridan Books, Inc. United States of America

EILEEN STILLWAGGON AND LARRY SAWERS

28

UNDERSTANDING HIV/AIDS IN THE AFRICAN
CONTEXT

Note: This article should be read in conjunction with Reading 27.
Understanding HIV/AIDS in the African context is a
complicated endeavor. This article provides a serious con
trast to the previous reading, which emphasized the issue
of concurrency in sexual relationships in southern Africa.
In contrast, this article considers many broader interact
ing factors that provided conditions to make the HIV/
AIDS epidemic spread in sub-Saharan Africa.
Epidemics do not occur simply because a pathogen
crosses some geographical or biological barrier. Rather,
the overall context must be conducive to an epidemic. This
is one reason why epidemics are often associated with
wars (see Reading 32).
Like other sexually transmitted infections (STIs), HIV/
AIDS is only partially about sex. A variety of contextual
factors including nutrition, hygienic conditions, and pov
erty that can constrain the behavior of individuals also
affect disease transmission. Answering the question of why
there is such a high rate of HIV/AIDS in sub-Saharan
Africa requires an understanding and serious consideration
of the contexts—both epidemiological and socio-economic.
It is not sufficient to focus only on individual behavior. If
we look only at individual behavior, we are likely to exag
gerate the ability ofpeople to make choices within particular
social and economic contexts and also likely to underesti
mate the power of structural violence (see Reading 34).
This article first considers the disease burden and the
ecology of poverty in populations with high rates of HIV.
These factors make an individual more likely to become
infected, because undernutrition and infectious diseases,
such as other STIs, malaria, and schistosomiasis, lead to
burdens on a person's immune system.
The health systems in many sub-Saharan African
countries are so inadequate that the initial arrival of HIV/
AIDS was barely recognized—quite unlike the United
States. African health-care systems and epidemiological

surveillance systems are overburdened and underfunded.
Clinics often lack simple equipment like clean hypodermic
needles. There are so many variables interwoven in the
causation of the HIV/AIDS epidemic that it is probably
impossible to measure them all in randomized controlled
studies. It is certainly the case that the most basic epide
miological methods (like the 2*2 table) are inadequate
for explaining the complex interaction of causes.
Science, including research on the causes of disease,
is often polluted by the scientists' preexisting cultural as
sumptions and prejudices. This may be the case with as
sumptions about the sexual behavior of the other
societies—in this case, the historical stereotype ofAfricans
as hypersexualized may have led to an overemphasis on
sexual explanations for the spread of HIV/AIDS.
This tendency to discover things that we already be
lieve to be true is called confirmation bias. The only way
to circumvent such bias is through repeated study and
reanalysis. This article interrogates the concurrency hy
pothesis by critically examining the methods used by other
researchers. Such arguments about methods sometimes
seem unnecessarily trivial to students. In reality, however,
looking at the methods that studies use is critical to un
derstanding whether their findings are actually correct.
Remember that this article should be read in con
junction with the previous reading (Reading 27).
As you read this piece, consider the following
questions:
• The previous article concluded with two con
crete recommendations for future HIV/AIDS
prevention programs, but this article does not.
In your opinion, what do you think that the
authors would propose as solution(s) to the
complexity of the epidemic?

This article is original to this volume.
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• In your opinion, why has HIV/AIDS received
more attention than "old" health challenges
like undernutrition, malaria, schistosomiasis,
or the neglected tropical diseases?
• Consider the difference that the authors pro
pose between causes of cases and causes of
incidence. Might this difference reflect the way
that clinical doctors think, as opposed to
people who practice public health?
• In your opinion, are there really "methodologi
cal handcuffs" that can hamper progress in
health improvements? If so, what is the
solution?
• Do you think that an incomplete consideration
of a complex web of causation, as described
here, can be considered "false facts?"
• The authors of this article are economists. Do
you think that this makes a difference in their
approaches to global health?

Eileen Stillwaggon is a professor of economics
and Benjamin Franklin Professor of Arts and

Sciences at Gettysburg College. Her primary
interest has been on the relationship between
health and economic development, described
in her book, Stunted Lives, Stagnant Econo
mies: Poverty, Disease, and Underdevelopment
(New Brunswick, NJ: Rutgers University Press,
1998). Recognizing the problems with an indi
vidualized behavior approach to health inter
ventions for HIV/AIDS, she wrote AIDS and the
Ecology of Poverty (Oxford: Oxford University
Press, 2006)—about the same time as the pop
ular book discussed in Reading 27. She has also
done research on economic development in
Native American communities and in Latin
America. Larry Sawers is a professor of eco
nomics at American University, Washington,
DC. His major research interests are in the
causes of economic underdevelopment, one of
which is poor health, and economic develop
ment policy. He has been a Senior Fulbright
Scholar in Tanzania, Ecuador, and Lithuania. His
books include The Other Argentina: The Inte
rior and National Development (Boulder, CO:
Westview, 1996) and Emerging Financial Mar
kets in the Global Economy (co-editor with
Daniel Schydlowsky and David Nickerson; River
Edge, NJ: World Scientific, 2000).

arge events are almost never like a meteor hitting
the earth. They arise over time, from multiple,
often interacting causes. Wars result from the com
bined effects of economic, political, and sometimes
natural events. Famines reflect the inability to buy
food due to income loss as well as supply factors,
such as crop failures and logistical obstacles. Tradi
tional epidemiology has always recognized that
outbreaks of disease occur in a specific context of
environmental, social, and economic conditions.
For an individual, as for a population, "the epide
miology of an infectious disease reflects complex
interactions between the infectious agent, the host,
and the environment".1
We know a great deal about why epidemics
spread. Random introductions of pathogens into
human populations occur continually, but they

rarely lead to epidemics or pandemics. Favorable
conditions are necessary for a microbe to make a
person sick or for the disease to spread throughout
a population. Plague was introduced numerous
times into Europe before 1348 without pandemic
spread. But 30 years of falling per capita food con
sumption had weakened the population and pro
vided the conditions needed for the Black Death.2,3
For 100 years before 1991 there was no cholera out
break in the Americas, although cholera vibrio was
introduced into coastal waters throughout the region
on countless occasions. The return of cholera to the
hemisphere followed substantial deterioration in
sanitary conditions throughout Latin America
during the "lost decade" of the 1980s, a period of
economic crisis, decreased government social ex
penditures, falling incomes, and increasing

CONTEXT
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inequality. From one squalid slum to another, chol
era spread north and south from Peru across Latin
America.4
Epidemiological, clinical, and laboratory evi
dence show that HIV infection is influenced by the
same factors that promote transmission of other
infectious diseases. People with nutritional deficiendes, with parasitic diseases, whose general health is
poor, who have little access to health-care services,
or who are otherwise economically disadvantaged
have greater susceptibility to infectious diseases,
whether they are transmitted sexually or by food,
water, air, or other means. This essay examines the
spread of HIV/AIDS in sub-Saharan Africa using this
perspective, and shows how much writing about
AIDS in Africa has neglected to take these factors
into account.
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Nutrition

From 1988 to 1998, when emerging or localized HIV
epidemics developed into generalized epidemics in
sub-Saharan Africa, 30 percent of the population of
the region was malnourished.7 Malnutrition in
creases vulnerability to infectious and parasitic dis
eases generally, increases HIV viral load and viral
shedding, and undermines the integrity of the skin
and mucosa, thereby increasing sexual and vertical
transmission of HIV.8-15 (For numerous additional
sources on nutrition, see.)16 Malnutrition alone
cannot explain differences in HIV epidemics across
the globe, but, given the well-understood connec
tion between immune status and malnutrition, it
surely played a role in accelerating the spread of HIV
in sub-Saharan Africa.
Malaria

The Health Environment
of African AIDS
At the time the HIV epidemic was spreading in
Africa, the real annual income of the average person
in the United States was more than 60 times that of
the average Tanzanian or Malawian.5 Calorie intake
per person in sub-Saharan Africa had not increased
from 1970 to 2000 and was still only 70 percent of
the consumption level of industrialized countries.
Public and private spending on health services in
Canada was 200 times what it was in Ethiopia.5 Mal
nutrition and parasite infection contribute to greater
susceptibility to any infectious disease, including
those transmitted sexually. There are also certain
diseases prevalent in Africa, but rare in the rest of
the world, that sharply increase the probability of
transmission of HIV.
When HIV emerged in the early 1980s, it was
barely noticed in some African countries because of
the routine enormity of suffering. Even today, HIV
is far from the only threat to poor people in the
region. When the HIV epidemic was already ad
vanced in Malawi, a study of a plantation there re
ported three deaths per month from AIDS, certainly
aterrible toll. But there were six non-AIDS deaths of
adult workers per month, and 15 deaths per month
of workers' dependents.6 HIV flourishes where
people are dying of other diseases. That is not mere
coincidence.

When generalized epidemics of HIV were develop
ing in the region, there were nearly 200 million cases
of malaria in Africa every year and nearly 1 million
deaths.17-18 At the time, Uganda, Tanzania, and Mo
zambique had the highest incidence of malaria in
the world, and Malawi, Zambia, and Zimbabwe were
not far behind.19 Then as now, more than
90 percent of acute infections and deaths from ma
laria were in sub-Saharan Africa.17 Malaria increases
HIV viral load up to ten times for as much as seven
weeks after an episode of fever, and that can more
than double heterosexual transmission.20-22 An HIVinfected person could have elevated viral load for
more than half of every year since people are repeat
edly reinfected in highly endemic areas.
Malaria also leads to anemia and impairs immune
response, both of which make those with HIV more
contagious.23 Malaria is especially dangerous in areas
of southern Africa where it occurs in seasonal epi
demics (Botswana, Zimbabwe, Swaziland, South
Africa, and Namibia), which are also the countries
with the highest rates of HIV.24
Helminths
Infection with helminths, or parasitic worms, im
pairs immune response and increases HIV viral load,
increasing transmission of HIV and accelerating pro
gression to AIDS.25-28 Because helminth infection is
so prevalent in sub-Saharan Africa, even a small
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additional risk of HIV transmission due to helminth
infection could mean many additional HIV infec
tions overall. A double-blind, controlled trial found
that treating worm infections in HIV-infected per
sons results in a statistically significant improvement
in immune system functioning.29,30 That suggests
that a simple, inexpensive (2 US cents) and effective
deworming medication could allow HIV-infected
people to be healthier while reducing the risk of in
fecting a partner, especially when antiretroviral treat
ment for HIV may be unavailable.
Schistosomiasis

Nearly 90 percent of cases of the parasitic disease,
urogenital schistosomiasis, occur in sub-Saharan
Africa, where it afflicts 120 million people.31,32 Schis
tosomiasis is highly prevalent in almost every coun
try in sub-Saharan Africa. Schistosome worms and
their eggs colonize the reproductive tract in men and
women, causing inflammation, viral shedding, and
genital ulcers, all of which increase the transmission
efficiency of HIV.33-36 In endemic areas, from 33 to
75 percent of women have genital lesions and in
flammation resulting from schistosome eggs.37 The
presence of eggs causes inflammation in the urogeni
tal system and breaches in the integrity of the epi
thelial layer and the protective mucosal surface.32,37,38
Women with genital ulcers of schistosomiasis have
three to four times the risk of being infected with
HIV as women in the same village without genital
ulcers of schistosomiasis.37'40
Treatment with praziquantel is effective in killing
the worms and stopping egg production and is safe
even in pregnancy and during lactation. Lack of
access to treatment can produce irreversible damage
to the reproductive tract. Praziquantel costs US
$0.30 per treatment, and even a single treatment in
childhood can reduce adult disease by half. Fewer
than 8 percent of people in need are treated al
though mass drug administration is feasible and
inexpensive.32,41

years (DALYs) per 100 000] was nearly six times the
mean burden outside the region, and all 47 subSaharan African countries for which there were data
were among the world's 52 countries with the highest
ST1 burden.19 Poor access to health care services, an
tibiotics, and antivirals contributes to the persistence
and spread of STIs in the region,43 in spite of unex
ceptional or even conservative sexual behavior docu
mented in empirical studies (see below).
Some STIs produce ulceration of the genitals that
are open pathways for transmission of HIV. All sexu
ally transmitted infections produce inflammation,
increased HIV shedding, and increased viral load,
all of which have been shown to increase the risk of
HIV transmission. Numerous observational studies
since the late 1980s demonstrate that STI coinfec
tions make persons with HIV more contagious and
make STI-infected persons more vulnerable to HIV
acquisition.27,43-48 STI diagnosis and treatment have
been standard parts of the HIV prevention toolkit
since the 1980s.
Non-Sexual Transmission

In addition to diseases that can increase HIV trans
mission rates during heterosexual and mother-tochild exposure, non-sexual modes of transmission
could play an especially important role in subSaharan Africa and among other poor populations.
There are numerous, common medical blood expo
sures (for example, injections with unsterilized sy
ringes, blood transfusions, catheter and intravenous
placements, and internal obstetrical examinations)
and non-medical blood exposures (for example,
barbering and hairdressing, tattooing, scarification,
injections given by non-medical personnel, and in
travenous recreational drug use) that can potentially
transmit HIV.49-51 Even if each one of those possible
non-sexual routes of transmission produces only a
small share of new infections, together they would
play an important role in the epidemics of subSaharan Africa, where sterilization equipment in
clinics could be lacking.

Other Sexually Transmitted Infections

Sub-Saharan Africa has the highest burden of sexu
ally transmitted infections (STIs) of all of the world's
regions.19,42 In 2004, the mean burden of STIs in subSaharan Africa [measured in disability-adjusted life

AIDS Policy in Africa
Since the argument above is well supported in main
stream epidemiology and in scientific research over
the past four decades, why is it not reflected in AIDS
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policy for sub-Saharan Africa? Why does funding
for HIV prevention not cover prevention of co-factor
infections, including malaria, urogenital schistoso
miasis, and STIs?
There are several reasons for the departure of
AIDS research from traditional epidemiology. Over
the course of the twentieth century, the emphasis of
medical research shifted from environmental and
population-level factors to individual-level theories
of disease causation,16'52-54 and that change became
evident in the evolution of AIDS discourse towards
a focus on individual factors, in particular sexual
behavior. We return to those methodological issues
later in the essay. Here we examine the overwhelm
ing emphasis on sexual behavior in HIV-prevention
policy.
In the 1980s and 1990s, the enormity and speed
of the AIDS pandemic were menacing. An incurable
disease was spreading both in the West and in
Africa, and ignorance of Africa served to allay West
ern fear by constructing AIDS as a disease of the
social Other. Western stereotypes had long por
trayed Africans as exotic and hypersexualized. No
tions of racial difference pervaded the social science
literature on AIDS in Africa and were especially
explicit during the first 15 years of the epidemic. No
one used the word race, but the notion entered into
the discourse as "culture." Racial "science" in an
earlier epoch and popular racial stereotypes that
persist to the present day stress sexual differences
between the races and portray sub-Saharan Africans
as exotic, strange, and even disturbing.55-57
By the late 1980s, the presumption, promoted
in scholarly and popular literature, that the
extraordinary nature of heterosexual behavior in
sub-Saharan Africa explained the high prevalence
of HIV in the region became widely accepted among
researchers and policy makers. Influential and
frequently cited works were characterized by
sweeping statements about pan-African sexuality,
either without evidence or with only anecdotal
evidence dating from the 1920s to the 1970s.
Through suggestive language and innuendo, they
conveyed the impression of Africans bent on selfdestruction because of cultural factors that
differentiated them from everyone else. (See among
others.58,59 For extensive discussion of racial
innuendo in AIDS discourse, see).16'60
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Racial stereotypes continue to pervade Western
culture, casting their shadow over scholarship and
public policy, even among persons who, on a con
scious level, vigorously and sincerely oppose racial
discrimination. The influence of notions of "race"
in both the popular mind and in the imagery of
science is insidious and difficult to counter because
so much of racial stereotyping is in the "unstated
assumptions and unthinking responses",61 rather
than in explicit postulates. That is aggravated by the
tendency for both academic and journalistic writing
about sub-Saharan Africa to consist of a "repertoire
of amazing facts".62 Writing about sub-Saharan Af
ricans, popular and scholarly, almost always empha
sizes how they are different from others, not their
commonality with people everywhere.
Western researchers, editors of academic jour
nals, bilateral donor agencies, and international
organizations framed the spread of AIDS in
sub-Saharan Africa in behavioral terms, neglecting
the health environment in which the epidemic un
folded in the region. The power to define the causes
of HIV in exclusively behavioral terms narrowed the
research questions and policy responses. In spite of
the lack of evidence, the theme in much AIDS schol
arship and policy literature remains that "Africans
are not like everyone else."
Inconsistencies in the Behavioral Paradigm

Serious researchers naturally sought data on sexual
behavior to test the proposition that differences in
sexual behavior could explain 50-fold differences in
HIV prevalence between some African countries and
the rest of the world. The UN Global Programme on
AIDS, the Demographic and Health Surveys (DHS)
funded by USAID, and numerous other researchers
have produced a substantial body of survey research
on sexual behavior in Africa and elsewhere. The sur
veys demonstrate that within every country there is
considerable variation in sexual behavior—some
people have many partners, for example, but most
people have one, very few, or none—and prevalence
of HIV across the globe and within sub-Saharan
Africa does not correlate with patterns of risky be
haviors. Evidence from those surveys showed that
in sub-Saharan Africa sexual behavior was more
conservative than in Europe, the United States,
Canada, and Latin America, whether measured by
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average age of sexual debut, prevalence of pre- or
extra-marital sex, average number of partners, visits
to commercial sex workers, or average number of
partners in one year or over a lifetime.63 64 (For ex
tensive documentation, see).16,65
In the 1990s, a second important finding fur
ther undermined the validity of the behavioral
paradigm. Researchers found that HIV is not a
particularly virulent pathogen and that per-act
transmission rates are quite low between other
wise healthy adults in heterosexual contacts,
though somewhat higher during the first few
weeks after initial infection. 66-70 Thus, empirical
evidence on both the behavior and the biology
needed for a behavioral explanation was lacking.
Nevertheless, AIDS had become associated in the
popular imagination, including that of research
ers, as an exceptional, African behavioral phenom
enon. Because asking how Africans are different
from everyone else seemed so reasonable to most
people, a new variant, the concurrency hypothesis,
became the conventional wisdom without credible
empirical support.
Concurrency to the Rescue

In the early 1990s, a few researchers proposed that
long-term overlapping partnerships—also called
multiple concurrent partnerships, or concurrency—
might explain the difference in HIV prevalence be
tween Africa and the rest of the world.71,72 A decade
later, it was clear that other forms of heterosexual
behavior could not account for the extraordinarily
high HIV prevalence in the region, and concurrency
emerged as the dominant explanation.73-75 It was
argued that concurrency—in contrast to one-time
or short-term sexual encounters—could permit suf
ficiently frequent sexual exposures during the first
few weeks of HIV infection, when transmission ef
ficiency is highest, to provide the missing engine
capable of driving the African HIV epidemics.
The promoters of this updated version of the be
havioral paradigm asserted that long-term concur
rent partnerships are unusually common in
sub-Saharan Africa.73-79 Furthermore, they asserted
that concurrent partnerships spread HIV much
more effectively than sequential multiple partner
ing.75 If either assertion is incorrect, then the

concurrency hypothesis fails. We argue that neither
is correct.
Is Concurrency More Common in Sub-Saharan
Africa?

In 2010, we reviewed more than three dozen studies
that proponents of the concurrency hypothesis had
presented as evidence of extraordinarily high con
currency prevalence in sub-Saharan Africa.65 We
found more than 100 errors in their reporting of the
results of those surveys. Moreover, most of the sur
veys recruited (rather than randomly sampled) a
small number of respondents, often in a single
neighborhood or village, so the results could not be
generalized to the larger population.65 The few sur
veys that randomly sampled a large population used
a measure of concurrency that has been judged un
reliable by the UNAIDS Reference Group on Esti
mates, Modelling and Projections.80 None of the
studies provided credible evidence that concurrency
was unusually high in sub-Saharan Africa.65 In 2010,
the DHS (Demographic and Health Surveys) began
to measure concurrency using the questionnaire
proposed by the UNAIDS Reference Group. There
are now surveys from 31 countries in sub-Saharan
Africa that interviewed a representative national
sample of adults, all using the same definition of
concurrency.81-82 The average prevalence of concur
rency (having overlapping sexual partnerships
six months prior to the interview) was
8.3 percent for men and 1.0 percent for women, or
4.7 percent for all adults age 15 to 49. Concurrency
prevalence in the United States and several Euro
pean countries is in the same range as the numbers
from sub-Saharan Africa, though perhaps higher for
women and lower for men.83-85
Is Concurrency Especially Effective in
Spreading HIV?

One cannot conduct trials with humans to test if
concurrency is an especially effective mechanism
for spreading HIV, so to explore the issue one must
use mathematical modeling of sexual networks, spe
cifically using a technique called individual-based
stochastic simulation modeling. The modeling takes
a number of factors into account, including the aver
age length of each partnership, the likelihood of
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forming a concurrent partnership, and the daily risk
or probability of acquiring HIV (which in turn im
plicitly assumes the frequency of sexual contact in
each partnership). For the modeling to generate
useful results, these parameters must be based on
reasonable estimates from survey research or clinical
studies. Early modeling appeared to show that HIV
spreads far more rapidly with concurrent partnering
than with serial monogamy.75 Those results were
cited by the modelers themselves and many others
to make the claim that concurrency explained ex
ceptionally high rates of HIV in sub-Saharan Africa.
That proposition soon became widely accepted.
The original model, however, depended on pa
rameters that were simply implausible. The modelers
assumed that every person, male or female, had sex
with every partner every day, with up to four part
ners. Moreover, they assumed that each day, in each
sexual partnership, there was a 5 percent chance of
HIV transmission. That 5 percent transmission risk
is nearly 100 times larger than the consensus risk
estimate of experts on the subject. Eaton and col
leagues86 adapted the original model's code and as
sumed an evidence-based per-day transmission risk.
They found that HIV either does not spread through
sexual networks at all or spreads far more slowly
than the original model found.
We built on Eaton's work by assigning realistic
values for other model parameters. Based on survey
research in sub-Saharan Africa, we assumed that
partnerships there, like everywhere else, last for
many years. We also assumed that secondary part
nerships have shorter durations on average and lower
frequency of sexual contact than primary (marital
or cohabiting) partnerships. With all of those errors
corrected, the restructured model cannot generate
any HIV epidemic that does not move to extinction,
that is, the epidemic collapses on itself. That remains
so whatever level of concurrency one assumes, even
levels far above those considered in the original
model and far above levels reported in the DHS sur
veys in sub-Saharan Africa.81'82'87
: In sum, when properly measured, levels of con
currency in sub-Saharan Africa are not unusually
high and, when properly modeled, concurrency at
even implausibly high levels cannot produce sustain
able simulated HIV epidemics. Thus, the concurrency
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hypothesis, the last bulwark of the behavioral para
digm, is without empirical or theoretical validity.
And yet, HIV-prevention policy is still rooted in a
behavioral, rather than a biomedical model.

What Should Inform AIDS Policy?
We have discussed how Western stereotypes of a
hypersexualized pan-African culture, rooted in a
belief that Africans are not like other people, al
lowed behavioral explanations to dominate the
search for causes of high rates of HIV in sub-Saharan
Africa. There are, however, methodological obsta
cles that also have prevented epidemiologists and
public health practitioners from using the biomedi
cal evidence described earlier in this essay. The in
creasingly individual-level focus of medicine and
public health was aggravated by the excessive reli
ance on experimental and statistical methods that
intentionally omit from consideration the context
in which individual illness or population-wide out
breaks occur.
AIDS discourse about Africa and HIV-prevention
policy are derailed by confusion over what Rose calls
"causes of cases and causes of incidence".52 Indi
vidual risk factors that are associated only with one
proximate cause (such as sex) do not fully explain
why one individual becomes infected and another
does not, nor do they explain why one population
has higher incidence than another.
Poor nutrition, malaria, helminths and STIs
make each sex act and each birth more risky in subSaharan Africa and accelerate epidemics of HIV in
the region. By targeting only one proximate cause,
sex, policy makers ignore the fundamentally differ
ent distribution of risk factors between sub-Saharan
Africa and affluent, temperate-zone regions. The
'background noise' of an environment teeming with
bacterial, viral, and parasitic cofactors is the appro
priate object of study to understand causes of ele
vated HIV risk for individuals and higher incidence
in sub-Saharan Africa.
Methodological Handcuffs

Any causal explanation must involve some simpli
fication, but randomized controlled trials (RCTs)
are designed to evaluate the effects of just one sin
gular cause. RCTs are essential in the evaluation of
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new drugs for which the effectiveness and harmful
effects are unknown, but they are blunt instru
ments for understanding infections or other
pathologies that arise from multiple interacting
causes, or evaluating public health interven
tions.8889 Epidemics are complex systems; trials
that attempt to change one part of that system may
show unreliable results because of multiple causes
and delayed effects.90,91
Trials of vitamin A supplementation for HIVinfected pregnant women reveal the difficulty of
attempting to isolate one factor in a complex terrain.
Observational studies indicated that women who
were deficient in vitamin A were more likely to
transmit HIV to their infants,92 but most trials of
vitamin A supplementation failed to demonstrate a
statistically significant difference in newborn
infection,93 although one trial supported the
hypothesis.94 Erroneously, some concluded that it is
pointless to provide supplements to pregnant,
vitamin-A deficient, HIV-infected women, in spite of
known benefits of supplementation for women's
health. Trial design permits only the conclusion that
an intervention is or is not a unique solution. The
trial cannot evaluate partial solutions or contributing
causes. It does not matter how precise the answers are
in such trials; their results are inaccurate because they
do not include all causes. They are what physicists
have called "not even wrong," because they do not
ask the right questions and thus omit relevant data.
The STI-HIV Treatment Trials: Where Context
Is Everything

Another example of the attempt to understand HIV
without understanding its context is the case of the
STI-HIV treatment trials. In the 1990s, a random
ized controlled trial showed that even modest ef
forts to improve the quality of diagnosis and care
for STIs in Mwanza, Tanzania led to a nearly
40 percent lower HIV incidence in communities
with those interventions than in communities with
out the interventions.95 Nevertheless, nine subse
quent trials in diverse locations in sub-Saharan
Africa using a variety of interventions did not find
a statistically significant difference in HIV inci
dence between two or more randomly selected
groups. There were, however, methodological flaws

in each of those trials that make it invalid to draw
policy conclusions from them. (For citations to all
trials, see.)48
RCTs require clinical equipoise, which means
that the researchers really do not know if the inter
vention is beneficial, considering both its efficacy
and its side effects. STIs are serious, sometimes dev
astating diseases. Medications to treat almost all
STIs were shown in earlier trials to be effective and
have few side effects. Observational data and the
Mwanza trial indicated, moreover, that STI treat
ment could decrease HIV incidence. Consequently,
ethical conduct in all the trials after Mwanza re
quired that participants in both intervention and
control groups in the study received STI treatments.
There was thus little difference in exposure (the in
terventions being tested) between the intervention
and control groups and so one could expect little
difference in HIV incidence between the two groups.
In statistical terms, the post-Mwanza trials were un
derpowered to detect a statistically significant dif
ference in HIV incidence. Since it is impossible to
construct ethical and meaningful RCTs to measure
the impact of STI treatment on HIV transmission, it
was inappropriate to throw out evidence from scores
of observational studies that demonstrated the ef
ficacy of STI treatments and the likelihood of reduc
ing HIV incidence. STI treatment is a neglected
intervention in HIV prevention and public health
generally. (For examination of numerous other
methodological problems with the 9 post-Mwanza
trials, see.)48
Many policymakers also dismiss treatment of
schistosomiasis as an HIV-prevention strategy, citing
those same STI trials. There is no doubt that treating
schistosomiasis would alleviate substantial urogeni
tal morbidity and other health problems at low cost.
What is contested is whether praziquantel should be
a standard part of HIV prevention. The observed
three- to four-fold increase in HIV acquisition in
several studies39,96 suggests substantial attributable
risk and should be sufficient to warrant wide imple
mentation of praziquantel treatment. Given the high
prevalence of schistosomiasis, over 120 million
infected in sub-Saharan Africa, even a small increase
in risk of HIV transm ission would generate very large
numbers of new HIV infections.
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When an intervention is beneficial in itself, is
safe, inexpensive, and logistically simple to admin
ister in resource-poor settings, it does not make
sense to impose the same burden of proof as one
would for an intervention that is untested, or risky,
or expensive, or complicated, such as for new drugs
in the research phase.97-99
Emerging Understanding of Emerging
Infectious Diseases

The mucosa of the genital tract is not a mere
mechanical barrier. It is more accurate to refer to the
microbial community of the genital tract as the
ecosystem in which sex takes place. Poor genital
health constitutes a disruption of vaginal microbial
communities.91 STIs can cause lesions that later
become infected with staphylococci and streptococci.
Antibiotics for bacterial STIs are ineffective in
treating those secondary infections. Treating
schistosomiasis, or STIs, is clearly beneficial, as it
begins the restoration of genital health. But each
treatment taken in isolation might not register as
statistically significant due to the presence of
inflammation or lesions from other causes. Recovery
of the environmental balance may well exceed the
time frame of an RCT. The response to an inadequate
statistical methodology should not be to reject a
beneficial intervention.
The multiplicity of environmental risks could seem
like an insurmountable barrier to HIV prevention.
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On the contrary, it presents a range of opportunities.
Even small improvements in the health of'sick popu
lations' could have large population-wide effects on
HIV spread.52 In complex systems, small differences
in initial conditions can result in large differences in
outcomes. Moreover, multiple interactions provide
multiple entry points to improve health and improve
resistance to new threats.90
In order to implement integrated disease preven
tion and treatment, changes are also needed in the
methods of health economic analysis. Just as health
research has been limited by a silo approach, eco
nomic studies attempt to measure the costs and ben
efits of interventions in isolation. Treatment for
schistosomiasis or STIs, for example, has spillover
effects on vulnerability to other diseases, the ben
efits of which are not generally considered in an
economic analysis of a single intervention. This is
true for spending outside the health sector as well.
One intervention—in sanitation, education, health,
job creation—can have multiple beneficial effects
that are mutually reinforcing.,00'101 Recognition of
spillover benefits and financing interventions across
multiple budgets would enable policymakers to
have a greater impact in choosing interventions with
high impact at lower cost. Solutions to global health
problems are easier to identify and cheaper to imple
ment with recognition of the interaction among
pathogens, hosts, and the environment, which
shapes the context of health and disease.
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